Neuromodulation

Neuromodulation is a rapidly advancing medical field focused on adjusting nervous system activity within the central, peripheral, or autonomic systems. This discipline leverages targeted interventions to manage chronic neurological and psychiatric disorders by modifying abnormal neural activity. Techniques like spinal cord stimulation, deep brain stimulation (DBS), vagus nerve stimulation (VNS), and transcranial magnetic or electrical stimulation are used to address specific neural circuits associated with symptoms. These interventions aim to restore function and improve quality of life by optimizing neural pathways.

Devices in neuromodulation span a spectrum of invasiveness, from non-invasive technologies, such as FES systems, to implantable devices like spinal cord stimulators. These tools enable clinicians to tailor treatments, addressing conditions ranging from chronic pain to motor impairments. Advances in artificial intelligence (AI) are further enhancing neuromodulation by improving patient selection, therapy optimization, and real-time decision-making. AI algorithms analyze large, multi-dimensional datasets to identify the best candidates for treatment, predict therapy outcomes, and fine-tune device parameters. This reduces trial-and-error approaches, shortens treatment cycles, and personalizes care, offering better outcomes for patients while optimizing clinical workflows.

MyndTec’s latest innovation to improve outcomes for spinal cord stimulation (SCS) patients focuses on enhancing patient selection through the integration of advanced machine learning within a decision support system (ML-DSS). By analyzing comprehensive patient datasets—including demographics, pain characteristics, treatment history, and therapeutic responses—the ML-DSS identifies individuals most likely to benefit from SCS therapy. This innovation reduces the trial-and-error process in patient selection, ensuring a higher success rate and more efficient use of resources. With its data-driven approach, MyndTec’s ML-DSS empowers healthcare providers to deliver precision care, improving outcomes and transforming the management of chronic pain. Learn more about this personalized AI-driven solution.

MyndMove™ is an advanced non-invasive neuromodulation therapy designed to restore voluntary motor function in individuals with upper-limb paralysis caused by stroke or quadriplegia. Using functional electrical stimulation (FES), MyndMove™ delivers targeted electrical impulses to stimulate neural pathways associated with movement while patients actively engage in attempting the desired actions. This process leverages neuroplasticity, enabling the brain to reorganize and establish new neural connections for sustained functional recovery. Clinical studies highlight significant improvements in voluntary movement, muscle strength, and quality of life for both acute and chronic paralysis patients. As a non-invasive and effective therapy, MyndMove™ exemplifies the transformative potential of neuromodulation in restoring independence and improving outcomes for individuals with severe motor impairments. Learn more about MyndMove